Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Teva
Citi
Healthtrust
Covington
Moodys
QuintilesIMS
Colorcon
Chubb
Daiichi Sankyo

Generated: October 18, 2017

DrugPatentWatch Database Preview

TENEX Drug Profile

« Back to Dashboard

Which patents cover Tenex, and what generic Tenex alternatives are available?

Tenex is a drug marketed by Promius Pharma and is included in one NDA.

The generic ingredient in TENEX is guanfacine hydrochloride. There are seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.

Summary for Tradename: TENEX

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list43
Clinical Trials: see list12
Patent Applications: see list537
Drug Prices:see details
DailyMed Link:TENEX at DailyMed

Pharmacology for Tradename: TENEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-001Oct 27, 1986ABRXYesNo► Subscribe► Subscribe► Subscribe
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-002Nov 7, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-003Nov 7, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TENEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-001Oct 27, 1986► Subscribe► Subscribe
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-003Nov 7, 1988► Subscribe► Subscribe
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-002Nov 7, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Colorcon
Chinese Patent Office
Express Scripts
AstraZeneca
US Department of Justice
Daiichi Sankyo
McKesson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot